Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.4762
H.R.4762: REGROW Act
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced March 16, 2016
- Latest Major Action March 18, 2016
Bill Sponsor
Bill Cosponsors
4 (1 Democrat, 3 Republicans)
Bill Summary
Reliable and Effective Growth for Regenerative Health Options that Improve Wellness or the REGROW Act This bill amends the Public Health Service Act to require the Food and Drug Administration (FDA) to conditionally approve certain cellular therapeutic products without initiation of large-scale clinical trials. A conditionally approved cellular therapy may be marketed if certain conditions are met, including conditions on the source,...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| March 18, 2016 |
Referred to the Subcommittee on Health.
|
| March 16, 2016 |
Referred to the House Committee on Energy and Commerce.
|
| March 16, 2016 |
Introduced in the House by Mike Coffman (R-Colo.) |